Remeron and Platelet count abnormal - a phase IV clinical study of FDA data

Summary:

Platelet count abnormal is reported as a side effect among people who take Remeron (mirtazapine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Nexium, and have Polycythaemia vera.

The phase IV clinical study analyzes which people have Platelet count abnormal when taking Remeron. It is created by eHealthMe based on reports of 24,977 people who have side effects when taking Remeron from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,475 Remeron users. Check the latest studies of Remeron.

What is Platelet count abnormal?

Platelet count abnormal is found to be associated with 539 drugs and 589 conditions by eHealthMe. Check the latest studies of Platelet count abnormal.

On Aug, 09, 2026

24,977 people reported to have side effects when taking Remeron.
Among them, 16 people (0.06%) have Platelet count abnormal.

Could Remeron cause Platelet count abnormal?

Among these 16 people:

How long have people been on Remeron when they have Platelet count abnormal? *

What is the gender of people who have Platelet count abnormal when taking Remeron? *

female: 75 %
male: 25 %

What is the age of people who have Platelet count abnormal when taking Remeron? *

What are other drugs people take besides Remeron? *

What are other side effects people have besides Platelet count abnormal? *

Nausea (feeling of having an urge to vomit): 9 people, 56.25%
Fatigue (feeling of tiredness): 8 people, 50.00%
Haemoglobin Decreased: 6 people, 37.50%
Bone Pain: 5 people, 31.25%
Red Blood Cell Count Decreased: 5 people, 31.25%
Nausea And Vomiting: 5 people, 31.25%
Balance Disorder: 5 people, 31.25%
White Blood Cell Count Decreased: 4 people, 25.00%
Pituitary Tumor: 4 people, 25.00%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 4 people, 25.00%

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 25.00%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 6.25%
Pain: 1 person, 6.25%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 1 person, 6.25%
Ovarian Cancer (cancer of ovary): 1 person, 6.25%
Lung Squamous Cell Carcinoma Stage Iv (the lung cancer has spread to the other lung, and/or to lymph nodes, fluid around the lungs or heart, and/or other places in the body, such as the brain, liver, adrenal glands, kidneys, or bones): 1 person, 6.25%
Hepatocellular Carcinoma (liver cancer): 1 person, 6.25%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and have Platelet count abnormal?

- Check whether Platelet count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remeron:

Remeron (26,475 reports)

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet count abnormal:

Platelet count abnormal (539 drugs)

Browse all the conditions that are associated with Platelet count abnormal:

Platelet count abnormal (589 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Remeron) and Remeron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.